Funded Tech Companies
ReviR Therapeutics
Wondering who provided funding to ReviR Therapeutics? CDH Investments, Yael Capital and 5Y Capital joined the equity holders in this innovative life sciences company.
Company Overview
Company Name
ReviR Therapeutics
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
150 North Hill Drive
Brisbane, CA 94005
USA
Brisbane, CA 94005
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
ReviR Therapeutics is a research and development company whose mission is to harness advanced technologies, machine learning/AI, and the inherent biology embedded within RNA to develop novel medicines to treat human disease. Our AI-based platform allows us to expand beyond the protein-based target space to reach a large number of known disease targets previously considered "undruggable"
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/29/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peng Yue
Chief Scientific Officer
Paul August
Vice President
Yang Liu
Vice President
Sridhar Narayan
VP - Bus. Development
Sarah Burnett
VP - R & D
Steve Lianoglou
Company Investors
- CDH Investments
- Yael Capital
- 5Y Capital
- Lapam Capital
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs